Take Home Naloxone: best practice in preventing fatal opioid overdoses for prison leavers
Best practice guidance on Take Home Naloxone (THN) for prison leavers from the Forward Trust presented as part of their ‘Pulse’ series of briefings.
European Drug Report: Trends and Developments 2019
The 2019 report from the European Monitoring Centre for Drugs and Drug Addiction has been released. This report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses.
Peer-To-Peer Distribution of Naloxone: Technical Briefing
This Technical Briefing provides a description of Peer-to-Peer Distribution of Naloxone (P2PN). This is based on six case studies of pioneers of P2PN; three from the UK and three international examples that inform the guidance in this Technical Briefing. This document will inform and be extended following a pilot of P2PN in four sites in England in 2019. These will be supported by small grants from EuroNPUD. The learning from this pilot will help test the model and peer education approach promoted in this briefing.
Widening the availability of naloxone
Guidance from Public Health England (PHE) on the supply of naloxone following the updates to ‘The Human Medicines Regulations 2019’. This guidance now includes the ability for UK drug services to supply nasal naloxone.
The Human Medicines (Amendment) Regulations 2019
The 2019 law amendments on the provision of take home naloxone in the UK, which, among other things, allow for the supply of intranasal naloxone.
Preventing overdose deaths in Europe
More than 9 000 lives were reported to be lost to drug overdoses in Europe (28 EU Member States, Turkey and Norway) in 2016, the latest reporting year, and this is an underestimate. Reducing drug-related deaths therefore remains a major challenge for public health policy. This analysis describes some of the factors that increase the risk of fatal and non-fatal overdoses and a number of interventions developed to prevent these events. Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.
